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BACKGROUND AND PURPOSE: ICAD with hemodynamic insufficiency may present with either fulmi-
nant infarct or with progressive neurologic deterioration. The purpose of this study was to evaluate the
safety and efficacy of emergent self-expanding stent placement for acute intracranial or extracranial
ICAD with significant hemodynamic insufficiency.
MATERIALS AND METHODS: Eight patients (7 men and 1 woman; age range, 20–55 years; NIHSS
score, 5–21) underwent emergent self-expanding stent placement for treatment of significant hemo-
dynamic insufficiency due to acute ICAD. The safety and efficacy of emergent self-expanding stent
placement were retrospectively evaluated.
RESULTS: All patients presented with progressive (n  6) or fluctuating (n  2) neurologic deficits and
revealed markedly decreased perfusion on CT or MR perfusion studies. Conventional angiography
revealed acute occlusion (n  2) or critical stenosis (n  6) in intracranial (n  3) or extracranial (n 
5) carotid arteries with a lack of sufficient collaterals. Stent placement was successful in all patients
without any procedure-related complications. In all patients, hemodynamic insufficiency was corrected
immediately after stent placement, and neurologic symptoms were completely resolved during several
days. Mean improvement of the NIHSS score between baseline and discharge was 11.6 (range, 5–21).
All patients remained neurologically intact (mRS, 0) during clinical follow-up for a mean of 21 months
(range, 8–50 months). Angiographic follow-up was available for 6 patients at 3–12 months. None of the
6 patients revealed residual or in-stent restenosis.
CONCLUSIONS: Self-expanding stent placement is a safe and effective option for selected patients
with significant hemodynamic insufficiency due to acute intracranial or extracranial ICAD.
ABBREVIATIONS: ICA  internal carotid artery; ICAD  ICA dissection; mRS  modified Rankin
Scale; NIHSS  National Institutes of Health Stroke Scale
Although carotid and vertebral artery dissections occur in aminority of patients with stroke, such dissections are rel-
atively common in young patients with stroke.1-3 The most
common complication of ICAD is embolization of thrombi
that develop on the intimal flap or in the pseudolumen.3 The
natural history of ICADmay follow a benign course with con-
servative management. Another mechanism of stroke is he-
modynamic insufficiency due to acute occlusion or critical
stenosis of the true lumen due to dissection with the lack of
sufficient collateral supply.4 In such cases, patients with ICAD
present with either fulminant infarcts at initial presentation or
with progressive neurologic deterioration. Therefore, early or
emergent intervention may be required to treat cases of ICAD
with significant hemodynamic insufficiency. In this study, we
evaluated the safety and efficacy of emergent self-expanding
stent placement for cases of intracranial or extracranial ICAD
presenting with progressive or fluctuating neurologic deficits
due to significant hemodynamic insufficiency.
Materials and Methods
The institutional review board approved this retrospective study. In-
formed consent was not required butwas obtained for pharmacologic
or mechanical thrombolytic treatment, including angioplasty and/or
stent placement, from the patients’ legal representatives. Eight pa-
tients underwent emergent self-expanding stent placement for treat-
ment of acute intracranial or extracranial ICAD in 3 territory referral
hospitals between April 2005 and November 2008. The patients in-
cluded 7men and 1woman,with amean age of 42 years (range, 20–55
years). The causes of ICAD were traumatic in 4 patients and sponta-
neous in 4 patients. The indications for stent placement were intra-
cranial or extracranial ICADs causing progressive or fluctuating neu-
rologic deficits in the presence of significant hemodynamic
insufficiency on CT/MR perfusion studies and occlusion or critical
stenosis with the lack of sufficient collateral supply on conventional
angiography.
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Intervention
Routine 3- or 4-vessel cerebral angiography was performed before
treatment. After identification of the location of the ICAD causing
acute occlusion or critical stenosis in the absence of sufficient collat-
erals, a guiding catheter (6F Envoy, Cordis, Miami Lakes, Florida; or
6F Shuttle-SL guide sheath, Cook, Bloomington, Indiana) was placed
at the proximal portion of the relevant carotid artery. Placement of a
self-expanding stent (Enterprise or Precise, Cordis; Neuroform or
Wallstent, Boston Scientific, Natick, Massachusetts) was the initial
mechanical maneuver for restoration of normal blood flow. The stent
Fig 1. A 35-year-old man with a spontaneous left cervical ICA dissection. A and B, Diffusion- (A) and perfusion-weighted (B) images reveal a large area of diffusion-perfusion mismatch,
suggestive of poor collateral circulation. C and D, Left common carotid angiograms reveal severe focal stenosis of the proximal left ICA due to dissection and also show poor visualization
of intracranial arteries. E, Angiogram immediately after self-expanding stent placement reveals complete restoration of normal luminal size of the left ICA and well-visualized intracranial
arteries.
Summary of clinical characteristics, treatment, and outcomes for 8 patients presenting with significant hemodynamic insufficiency due to ICA
dissection
No.
Sex/Age
(yr) Cause Location Treatment Indication Treatment
NIHSS
Score at
Treatment
NIHSS
Score at
Discharge
1 M/55 Traumatic Supraclinoid ICA, left Progressive neurologic deficit Enterprise 10 1
2 M/20 Spontaneous Supraclinoid ICA, right Fluctuating neurologic deficit Enterprise 5 0
3 M/45 Traumatic Supraclinoid ICA, left Progressive neurologic deficit Neuroform 8 0
4 M/35 Spontaneous Cervical ICA, left Progressive neurologic deficit Wallstent 21 0
5 M/42 Spontaneous Cervical ICA, left Progressive neurologic deficit Wallstent 17 0
6 F/53 Spontaneous Cervical ICA, right Fluctuating neurologic deficit Precise 5 0
7 M/42 Traumatic Cervical ICA, left Progressive neurologic deficit Wallstent 13 0
8 M/45 Traumatic Cervical ICA, left Progressive neurologic deficit Wallstent 15 0
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diameter was determined according to the diameter of the normal
carotid artery proximal to the dissection, and the length of the stent
was chosen to sufficiently cover the affected arterial segment. Any
available stent of appropriate diameter and length to match the dis-
sected ICA was used.
Embolic protection devices (FilterWire EZ, Boston Scientific or
AngioGuard, Cordis) were used in 3 of 5 cervical ICAD stent-place-
ment procedures. The use and choice of type of embolic protection
device were left to the operator’s discretion. Poststenting balloon an-
gioplasty was performed in 3 of 5 cervical ICAD stent-placement pro-
cedures, in which cases50% residual stenoses remained after stent
placement. For intracranial ICA dissection, embolic protection de-
vices and poststenting balloon angioplasty were not used due to both
the technical difficulty and concern about potential risk of arterial
injury. Immediately after stent deployment, a bolus of glycoprotein
IIb/IIIa antagonist (tirofiban, 0.5–1mg) was intra-arterially loaded in
all patients due to lack of antiplatelet premedication. Anticoagulation
was stopped, but intravenous infusion of glycoprotein IIb/IIIa antag-
onist (tirofiban) was maintained for 24–36 hours after completion of
the procedure. A loading dose of dual antiplatelet medication (aspi-
rin, 100–500 mg, plus clopidogrel, 300 mg) was administered imme-
diately after the procedure. Maintenance doses of dual antiplatelet
medication were administered for 3–6 months and then changed to
aspirin monotherapy indefinitely.
Results
The Table summarizes the clinical characteristics, treatments,
and outcomes of all 8 patients included in this study. All pa-
tients presented with progressive (n 6) or fluctuating (n
2) neurologic deficits. CT or MR perfusion was performed in
all patients, all of whom revealed markedly decreased perfu-
sion in the relevant brain parenchyma (Fig 1A, -B). The mean
NIHSS score at treatment was 11.7 (range, 5–21). Conven-
tional angiography revealed acute occlusion (n 2) or critical
stenosis (n 6) at the intracranial (n 3, Fig 2) or extracra-
nial (n 5) ICA along with a lack of sufficient collateral sup-
ply. Stent placement was successful in all patients without any
procedure-related complications. In all patients, hemody-
namic insufficiency was corrected immediately after stent
placement (Figs 1 and 2), and presenting neurologic symp-
toms were completely resolved during several days. The
NIHSS score at discharge was 0 in all patients except for 1 who
had an NIHSS score of 1. The mean improvement of the
NIHSS score between baseline and discharge was 11.6 (range,
5–21). All patients remained neurologically intact (mRS score,
0) during clinical follow-up for a mean of 21 months (range,
8–50 months). Angiographic follow-up was available in 6 pa-
tients at 3–12months. None of these 6 patients had residual or
in-stent restenosis.
Discussion
ICAD is an important cause of stroke in young ormiddle-aged
patients.1-3 Clinical manifestations of acute ICAD vary, with
local symptoms, cerebral ischemia, or both.3 In acute ICAD
presenting with ischemic symptoms, most strokes or transient
ischemic attacks are embolic in nature; therefore, they are
mostly associated with good outcomes after administration of
anticoagulation and/or antiplatelet medications.5-12 Although
stent placement for ICAD is both feasible and safe,13 it is re-
served for selected patients with ICAD with recurrent embo-
lism refractory to medication, with contraindications for
anticoagulation, or with persistent/enlarging pseudoaneu-
rysms.14-17 Stent placement for ICADs to reverse acute hemo-
dynamic insufficiency or impending infarcts is described in
only a few studies.18,19 Hemodynamic insufficiency due to
acute obstruction or critical stenosis caused by dissection plays
a key role in stroke progression in only a small number of
patients with acute ICAD when combined with a lack of suf-
ficient collateral circulation. In such cases, the patients have
complete stroke at initial presentation or present with pro-
gressive neurologic deficits.4
Kremer et al20 reported a benign clinical course of unilat-
eral ICAD causing severe stenosis or occlusion in 161 patients.
However, in that study, 4 patients with permanent and 5 pa-
tients with transient severe stenosis or occlusion were ex-
cluded because they had undergone either bypass surgery or
endovascular therapy for ICAD. Those 9 patients may be sim-
ilar to those included in this study. Therefore, in the study of
Kremer et al, approximately 5.6% (9/161) of patients with
acute ICAD required surgical or endovascular intervention at
initial presentation. Patients who survive severely stenotic or
occlusive ICAD without stroke or progressive neurologic def-
Fig 2. A 55-year-old man with a traumatic left intracranial ICA dissection. A, Left internal carotid angiogram reveals tapered occlusion of the left ICA just distal to the origin of the ophthalmic
artery. Facial CT scan showed a linear fracture of the left optic strut adjacent to the left carotid artery (not shown). B, Lateral angiogram immediately after self-expanding stent placement
shows recanalization of the ICA. Note incomplete expansion of the stent due to the remaining intramural hematoma (arrow). C, Follow-up lateral angiogram at 2 weeks reveals restoration
of normal luminal size of the left ICA. Note complete resolution of the intramural hematoma and full expansion of the stent (arrow).
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icits at initial presentationmay have sufficient collateral circu-
lation to relevant brain tissue.
Because most severe stenoses and some occlusions eventu-
ally recanalize within weeks or months, embolic phenomena
may be the only major complications in such patients.20,21
Therefore, conservative management with anticoagulation or
antiplatelet medication may be sufficient, and further inter-
vention may not be required in such patients. However, pa-
tients with impending infarcts or progressive neurologic defi-
cits due to significant hemodynamic insufficiencymay require
early or emergent surgical or endovascular intervention.4,18,19
In this study, all patients presentedwith progressive (n 6)
or fluctuating (n 2) neurologic deficits and revealed mark-
edly decreased perfusion on CT or MR perfusion studies.
Catheter angiograms also showed acute obstruction (n 2) or
critical stenosis (n 6) with a lack of sufficient collateral sup-
ply. On the basis of the progression of neurologic deficits and
radiographic findings, all patients underwent emergent self-
expanding stent placement for correction of acute hemody-
namic insufficiency due to intracranial (n 3) and extracra-
nial (n 5) ICADs. All patients experienced excellent clinical
and angiographic outcomes, with no procedure-related
complications.
To the best of our knowledge, only 1 case of intracranial
stent placement used to treat intracranially extended cervical
ICAD as a part of multiple stent placement has been described
in the literature.22 In that report, a self-expanding Neuroform
stent was deployed from the intradural supraclinoid to the
cavernous segment of the dissection, followed by tandem stent
placement of 4 balloon-expandable stents covering the extra-
dural-cavernous-to-cervical segments. Concerning the use of
self-expanding stents to treat dissection, Ansari et al23 re-
ported that the use of self-expanding Neuroform stents was
successful for the treatment of 2 cervical ICADs and 7 high
cervical or intracranial vertebrobasilar dissections.
In the current study, self-expanding stent placement was
used safely and effectively for the treatment of intracranial
ICADs and extracranial ICADs. It was also used in 2 obstruc-
tive and 6 stenotic ICADs. Our results correspond well with
those of previous case series showing that stent placement is
safe and effective for acute extracranial ICAD.14-19 Our results
also suggest that this treatment may be safe and effective for
intracranial acute ICAD. When stent placement is tried for
treating an intradural dissection, one can never be too careful
in navigating a guidewire to cross the dissection. Because the
intradural arteries have little external elastic lamina, proce-
dural rupture or aggravation of dissection may occur more
easily in intradural arterial segments than in the extradural
ones. Therefore, the guidewire should be withdrawn and
renavigated if any resistance is felt during navigation. Fortu-
nately, in all intradural ICA dissections in this series, the
guidewire was easily negotiated through the dissected segment
at the initial attempt. However, when difficulty is encountered
in passing a guidewire through the dissected segment with any
cause, an alternative surgical option, such as bypass surgery,
should be considered.
The long-term patency of stented ICAs is a concern. How-
ever, in this study, all 6 patients for whom follow-up angiog-
raphy was available revealed no residual or in-stent stenosis.
This result corresponds well with other results reported in the
literature.13,24 Therefore, delayed in-stent restenosis may not
be a significant problemwhen treating ICAdissection by using
stent-placement procedures.
Conclusions
Although most cases of ICAD have a good prognosis with
conservativemanagement, a small portion of ICAD cases with
hemodynamic insufficiency due to poor collateral circulation
may require immediate intervention. Self-expanding stent
placement seems to be a safe and effective option for selected
patients with significant hemodynamic insufficiency due to
intracranial and extracranial ICAD.
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